Mario Scuri

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial

Alberto Papi, Jørgen Vestbo, Leonardo M. Fabbri et al. · The Lancet · 2018 · 611 citations · Full text

Advanced Lung Disease, Respiratory Therapy, Pulmonary Pharmacology +5

Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial

Jørgen Vestbo, Alberto Papi, Massimo Corradi et al. · The Lancet · 2017 · 433 citations · Full text

Pulmonary Care, Pulmonary Pharmacology, Parallel Group +4

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

Dave Singh, Alberto Papi, Massimo Corradi et al. · The Lancet · 2016 · 412 citations · Full text

Advanced Lung Disease, Pulmonary Pharmacology, Parallel Group +4

The Lactoperoxidase System Functions in Bacterial Clearance of Airways

Cynthia Gerson, Juan Sabater, Mario Scuri et al. · American Journal of Respiratory Cell and Molecular Biology · 2000 · 173 citations

Inhaled tryptase causes bronchoconstriction in sheep via histamine release.

J F Molinari, Mario Scuri, William R. Moore et al. · American Journal of Respiratory and Critical Care Medicine · 1996 · 141 citations

Inflammatory Lung Disease, Lung Inflammation, Allergy Medicine +18